Back to search
FDAFDA · Food and drugs·Recall number Z-0862-2024

Senographe Pristina

Published February 14, 2024 · Recall initiated: December 26, 2023

Summary

FDA records medical device Class II recall Z-0862-2024, published February 14, 2024 and initiated December 26, 2023. Recalling firm: GE Medical Systems, SCS; Status: Ongoing; Reported quantity: 180 units (60 US; 120 OUS); Lot: GTIN(s): 195278022745, 195278276971, 195278628916, 195278661999, 195278665379, 840682118460, 840682142052, 840682145879. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

X-ray exposure termination audible signal on Senographe Pristina with Efficiency Suite 2 intermittently not emitted per 21CFR 1020.31(j) requirements.

What to do

FDA Mandated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GE Medical Systems, SCS
Distributor
Us Nationwide-Worldwide Distribution
Lot
GTIN(s): 195278022745, 195278276971, 195278628916, 195278661999, 195278665379, 840682118460, 840682142052, 840682145879
Risk classification
Class II
Area (FDA)
device
Country
France

Related recalls

Questions about this recall

Was Senographe Pristina recalled?

Yes. FDA published recall Z-0862-2024 on February 14, 2024. Reported hazard: X-ray exposure termination audible signal on Senographe Pristina with Efficiency Suite 2 intermittently not emitted per 21CFR 1020.31(j) requirements.

What should I do if I have this product?

FDA Mandated · Letter